Pascal Touchon, Atara CEO
Fujifilm completes acquisition of Atara's cell therapy manufacturing site near Los Angeles
In January, Atara Biotherapeutics inked a deal with Fujifilm Diosynth to exchange its California manufacturing site for $100 million upfront, and a long-term licensing deal …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.